Abstract 11650: Adcy9 Inactivation Improves Cardiac Function After Myocardial Infarction in Absence of Cholesterol Ester Transfer Protein

Pharmacogenomic studies have shown that polymorphisms in the adenylate cyclase 9 (ADCY9) gene influence the effects of dalcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, on cardiov...